Source: Eur Respir J 2005; 25: 751-757
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Dlodlo R. A., Fujiwara P. I., Enarson D. A.. Should tuberculosis treatment and control be addressed differently in HIV-infected and -uninfected individuals?. Eur Respir J 2005; 25: 751-757

Member's Comments

No comment yet.

Related content which might interest you: The treatment of tuberculosis and application of HAART (highly active anti retroviral treatment) in HIV positive patients Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem Year: 2005 The role of adherence in tuberculosis HIV-positive patients treated in ambulatory regimen Source: Eur Respir J 2003; 21: 785-788 Year: 2003 Tuberculosis in HIV-infected persons in the context of wide availability of highly active antiretroviral therapy Source: Eur Respir J 2004; 24: 11-17 Year: 2004 Impact of extensive drug resistance on treatment outcomes in non-HIV infected adults with MDR-TB Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Prevalence of HIV infection among tuberculosis cases and pattern of tuberculosis and treatment outcome in HIV seropositives – a study from a tuberculosis center from India Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 Clinical management of tuberculosis and HIV-1 co-infection Source: Eur Respir J 2010; 36: 1460-1481 Year: 2010 Challenges and perspectives for improved management of HIV/Mycobacterium tuberculosis co-infection Source: Eur Respir J 2010; 36: 1242-1247 Year: 2010 Prevalence and treatment outcome of drug resistant pulmonary tuberculosis in HIV negative cases – experience from a tuberculosis treatment center in India Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 HIV co-infection excludes many drug-resistant tuberculosis patients from clinical trials with novel antituberculosis drugs Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 The tuberculosis in patients with HIV and AIDS Source: Eur Respir J 2007; 30: Suppl. 51, 656s Year: 2007 The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results Source: Eur Respir J 2011; 38: 1374-1381 Year: 2011 Comparison of two different cohorts of patients for multidrug-resistant tuberculosis treatment evaluation Source: Annual Congress 2006 - Epidemiology and management of multidrug-resistant tuberculosis (MDR-TB) Year: 2006 Pre-immigration screening process and pulmonary tuberculosis among Ethiopian migrants in Israel Source: Eur Respir J 2008; 32: 413-418 Year: 2008 Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control Source: Eur Respir J, 50 (1) 1700004; 10.1183/13993003.00004-2017 Year: 2017 Functional and memory status of M. tuberculosis specific T-cells in HIV-infected patients naïve to antiretroviral treatment Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Tuberculosis (TB) detection with HIV infected patients Source: Annual Congress 2009 - Tuberculosis and HIV co-infection Year: 2009 A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014 Prevention of TB in areas of low incidence Source: Eur Respir Mon 2012; 58: 72-83 Year: 2012